Kota Itahashi

Tokyo, 2778577, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

Journal: Science translational medicine

Published: April 15, 2026

Intravesical recurrence is associated with increased Treg and exhausted CD8+ T cells in upper tract urothelial carcinoma.

Intravesical recurrence is associated with increased Treg and exhausted CD8+ T cells in upper tract urothelial carcinoma.

Journal: Urologic oncology

Published: February 20, 2026

The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment.

The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment.

Journal: Cancer immunology research

Published: July 29, 2024

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

Journal: Nature cancer

Published: March 15, 2024

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine.

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine.

Journal: Nature reviews. Clinical oncology

Published: February 12, 2024

Microbiota-driven antitumour immunity mediated by dendritic cell migration.

Microbiota-driven antitumour immunity mediated by dendritic cell migration.

Journal: Nature

Published: January 16, 2023

BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.

BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.

Journal: Science immunology

Published: October 07, 2022

Regulatory T-cell development in the tumor microenvironment.

Regulatory T-cell development in the tumor microenvironment.

Journal: European journal of immunology

Published: January 18, 2022

Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.

Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.

Journal: Science immunology

Published: November 12, 2021

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.

Journal: Cancer cell

Published: August 01, 2021

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704).

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 26, 2021

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab.

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab.

Journal: Nature communications

Published: September 07, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026